{"id":"W2789498468","doi":"10.1007/s40258-018-0371-0","title":"Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching","year":2018,"lang":"en","type":"letter","venue":"Applied Health Economics and Health Policy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University; University of Ottawa","funders":"Janssen Pharmaceuticals","keywords":"Biosimilar; Infliximab; Inflammatory bowel disease; Medicine; Incentive; Intensive care medicine; Payment; Health economics; Public economics; Risk analysis (engineering); Disease; Business; Public health; Economics; Finance","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002347656,0.0006071434,0.001253503,0.001057951,0.0009143308,0.00006816155,0.0004378347,0.001098961,0.00002069736],"category_scores_gemma":[0.0002286166,0.0006249727,0.0002545331,0.0001675089,0.0002953782,0.0001106058,0.000211538,0.001234609,0.00001900061],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001098562,"about_ca_system_score_gemma":0.005721538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001634748,"about_ca_topic_score_gemma":0.0005835667,"domain_scores_codex":[0.9950578,0.0002047875,0.001664219,0.00110822,0.00003828245,0.001926675],"domain_scores_gemma":[0.9970162,0.0009278253,0.001043529,0.0006099361,0.00007483563,0.0003276532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005425591,0.00008475119,0.0002491988,0.006528875,0.0001928373,0.00000128399,0.0008984255,0.0000186556,0.00003195239,0.05495462,0.9090187,0.02747814],"study_design_scores_gemma":[0.001947247,0.0003427051,0.001618737,0.0004733847,0.00003776291,0.000005207534,0.0000592107,0.0002633216,0.00001288291,0.02145614,0.9732249,0.0005584674],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0004500475,0.006782873,0.0007564328,0.9854336,0.0005240191,0.003864323,0.002074526,0.00005276014,0.00006143114],"genre_scores_gemma":[0.001322299,0.02638714,0.004699207,0.960225,0.005083504,0.001224079,0.0005546439,0.000131288,0.0003728493],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.06420624,"threshold_uncertainty_score":0.9999151,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09600940158023422,"score_gpt":0.4134414470554328,"score_spread":0.3174320454751987,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}